MLN0128: Pre-clinical drug screen reveals topotecan, actinomycin D and volasertib as potential new therapeutic candidates for ETMR brain tumor patients

AS1517499 : STAT6 blockade ameliorates thyroid function in Graves’ disease via downregulation of the sodium/iodide symporter

BMS-986165: Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors

NG25 : Optimization of pretreatment procedure for MeHg determination in sediments and its applications

Temozolomide: MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients